Huadong Medicine
Huadong Medicine
Huadong Medicine is a comprehensive pharmaceuticals company.
Huadong Medicine, founded in March 1993 and headquartered in Hangzhou, is a comprehensive manufacturer and distributor of various types of antibiotics, proprietary Chinese medicines, and synthetic drugs. The founder is Lu Liang. Listed on the Shenzhen Stock Exchange on January 27, 2020, the company's major shareholders are China Grand Enterprises and Hangzhou Huadong Medicine. The direct and indirect competitors of Huadong Medicine include Hengrui Medicine, Humanwell Healthcare, Kelun Pharmaceutical.
- All
- News
- Analysis
- Research
Briefing Nov 29, 2021 06:24 PM
· Healthcare
Aibo biology completed the round C + financing of US $300 million
Briefing Nov 29, 2021 02:14 PM
· Healthcare
Yuanyin biology completed the pre-A round of financing of more than 100 million yuan
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Nov 29, 2021 10:04 AM
· Healthcare
2021 Chinese hospital internet influence ranking list released 127 hospitals in 17 provinces and cities
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Real Estate, Industrials, FinancialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Briefing Nov 06, 2021 10:00 AM
· Healthcare
Du HaoChen, vice president of AstraZeneca China, is about to join Baiji Shenzhou
Briefing Nov 02, 2021 05:24 PM
· Healthcare
Ouyi biology completed round a + financing
Briefing Oct 29, 2021 11:38 AM
Financial Associated Press, October 29 - a carbon monoxide poisoning accident occurred in an ironmaking plant in Xingtai, Hebei Province. Three people died after ineffective rescue.
Briefing Oct 08, 2021 10:27 AM
· Healthcare
Yiyi biological submitted ryzneuta to the European drug administration ™ Listing application accepted
Insight
Healthcare
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
Briefing Jul 06, 2021 10:41 AM
· Healthcare
Yimei concept stocks all weakened, Aoyuan Meigu closed down
See more
Related Companies
EqualOcean Analysis
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- More Room for the Medical Device Market to Grow in China
- Modern Chinese Medicine Maker Tasly Pharmaceutical: An Old Stock in a New Package?
- Haier Balances Smart Home Demand at Home and Overseas Trends
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.